`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner,
`
`v.
`
`HORIZON THERAPEUTICS, LLC,
`Patent Owner.
`
`_____________________
`
`Case IPR2017-01767
`Patent 9,254,278
`_____________________
`
`JOINT STIPULATION TO REVISE SCHEDULE
`
`
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Joint Stipulation to Revise Schedule
`
`The Patent Owner and Petitioner give notice to the Board that they hereby
`
`
`
`jointly stipulate to revise the schedule, as indicated below. A complete listing of
`
`all DUE DATES, including this revision, follows:
`
`
`
`DUE DATE 1:
`
`May 2, 2018
`
`May 9, 2018
`
`DUE DATE 2:
`
`August 2, 2018
`
`August 16, 2018
`
`DUE DATE 3:
`
`September 3, 2018
`
`DUE DATE 4:
`
`September 24, 2018
`
`DUE DATE 5:
`
`October 8, 2018
`
`DUE DATE 6:
`
`October 15, 2018
`
`
`
`
`
`
`
`
`
`DUE DATE 7:
`
`October 29, 2018
`
`December 14, 20181
`
`
`
`
`
`
`
`
`1 Per IPR2017-01767, -01768, -01769, Order Rescheduling DUE DATE 7, entered
`July 30, 2018 (Paper 28).
`
`1
`
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Joint Stipulation to Revise Schedule
`
`Authorization for this stipulation is stated in the Scheduling Order entered
`
`
`
`January 30, 2018 (Paper No. 11), which permits the parties to stipulate to different
`
`dates for DUE DATES 1-5, provided none are later than DUE DATE 6.
`
`
`
`Dated: July 30, 2018
`
`
`Dated: July 30, 2018
`
`/s/David H. Silverstein
`David H. Silverstein (Reg. No. 61,948)
`Counsel for Petitioner
`Par Pharmaceutical, Inc.
`
`/s/Matthew C. Phillips
`Matthew C. Phillips (Reg. No. 43,403)
`Counsel for Patent Owner
`
`2
`
`
`
`
`
`IPR2017-01767
`Patent No. 9,254,278
`Certificate of Service
`
`CERTIFICATION OF SERVICE
`The undersigned hereby certifies that the above-captioned “JOINT
`
`STIPULATION TO REVISE SCHEDULE” was served in its entirety on
`
`July 30, 2018 through the Patent Trial and Appeal Board End to End (PTAB E2E)
`
`system, and additionally upon the following parties via Electronic Mail, as agreed
`
`to by counsel:
`
`Robert Green: rgreen@greengriffith.com
`Matthew Phillips: mphillips@lpiplaw.com
`Emer Simic: esimic@greengriffith.com
`Dennis Bennett: dennisbennett@globalpatentgroup.com
`Ann Kotze: akotze@greengriffith.com
`
`
`Dated: July 30, 2018
`
`
`
`David H. Silverstein (Reg. No. 61,948)
`AXINN, VELTROP & HARKRIDER LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`(212) 261-5651
`
`Counsel for Petitioner
`Par Pharmaceutical, Inc.
`
`
`
`
`
`
`